查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951874

合成生物學市場分析及預測（至2035年）：依類型、產品類型、服務、技術、組件、應用、最終使用者及流程分類

Synthetic Biology Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Process
出版日期: | 出版商: Global Insight Services | 英文 399 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

合成生物學市場預計將從2024年的137億美元成長到2034年的548億美元，複合年成長率約為15.4%。合成生物學市場涵蓋新型生物實體的設計和構建，以及現有生物系統的重新設計。它融合了生物學、工程學和電腦科學等領域，旨在為醫療保健、農業和環境永續性開發解決方案。在DNA合成、基因組編輯技術和生物資訊學進步的推動下，該市場為生物製藥、生質燃料和生物分解材料領域帶來了變革性的機會。不斷成長的投資和監管支持也進一步推動了其發展。

合成生物學市場正經歷強勁擴張，這主要得益於基因工程和生物資訊學的進步。在這個充滿活力的市場格局中，基因合成細分市場成長最為迅猛，這主要歸功於其在建構精確DNA序列方面所扮演的核心角色。合成基因日益廣泛地應用於製藥、農業和工業生物技術領域。第二大細分市場是基因組編輯，尤其是CRISPR技術，它徹底革新了標靶基因修飾。其應用範圍涵蓋了從培育抗病作物到創新療法等許多領域。生物資訊學領域也正蓬勃發展，它為分析複雜的生物數據提供了重要工具，這對於合成生物學的研發至關重要。代謝工程也展現出巨大的潛力，因為它能夠最佳化生質燃料和特用化學品的生產流程。這些細分市場的整合表明，市場正朝著提高效率和創新能力的整合解決方案發展。預計對合成生物學的投資將加速成長，從而在各個工業領域創造新的機會。

市場區隔
類型 基因迴路、宿主生物、DNA合成、基因組工程
產品 合成DNA、合成基因、合成細胞、外來產物、合成RNA
服務 基因合成服務、基因組編輯服務、生物資訊服務
科技 CRISPR、基因編輯、DNA定序、生物資訊學、基因合成
成分 寡核苷酸、酵素、克隆技術試劑盒、宿主生物
應用領域 醫療、工業、環境和農業應用
最終用戶 生技公司、製藥公司、學術研究機構
過程 通路工程、代謝工程、無細胞系統

合成生物學領域充滿活力，市場參與企業眾多。新參與企業不斷推出創新產品，進一步加劇了市場佔有率的分散化。隨著技術進步和競爭加劇，定價策略也不斷演變。頻繁的新產品發布是該行業的顯著特徵，反映了快速創新的發展。各公司致力於開發具成本效益的解決方案，以在這個快速成長的市場中擴大市場佔有率。對永續和環保產品的關注也影響著定價和產品開發策略。合成生物學領域競爭異常激烈，主要參與者都在努力取得技術優勢。基準數據顯示，主要企業正大力投資研發，以維持其競爭優勢。監管至關重要，北美和歐洲等地區實施了嚴格的政策。這些法規影響產品開發和打入市場策略。在基因編輯技術和生物資訊學進步的推動下，市場呈現成長跡象。然而，監管合規和倫理考量等挑戰依然存在。這些因素將對合成生物學市場的未來發展軌跡產生關鍵影響。

主要趨勢和促進因素：

合成生物學市場正經歷強勁成長，這主要得益於基因工程的進步和生物技術領域投資的不斷增加。關鍵趨勢包括新型合成生物體和生物基產品的開發，這些產品正在改變製藥、農業和能源等產業。人工智慧 (AI) 和機器學習與合成生物學的日益融合正在加速研發進程，從而實現更精準、更有效率的生物系統設計。另一個關鍵趨勢是對永續和環境友善解決方案日益成長的需求，這推動了合成生物學在可生物分解材料和可再生化學品開發中的應用。此外，學術機構、研究組織和產業界之間日益密切的合作正在促進合成生物學應用的創新和商業化。政府的支持和有利的法規結構進一步加速了市場擴張。此外，人們對個人化醫療的日益關注以及合成生物學在疾病治療領域革命性潛力也是關鍵促進因素。企業正在投資開發基於合成生物學的療法，這些療法有望提供目標有效的治療方法。隨著合成生物學不斷應對全球挑戰並在各個領域開拓新的機遇，預計該市場將實現顯著成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 基因迴路
    • 基礎生物
    • DNA合成
    • 基因組工程
  • 市場規模及預測：依產品分類
    • 合成DNA
    • 合成基因
    • 合成細胞
    • 異種生物製品
    • 合成RNA
  • 市場規模及預測：依服務分類
    • 基因合成服務
    • 基因組編輯服務
    • 生物資訊服務
  • 市場規模及預測：依技術分類
    • CRISPR
    • 基因編輯
    • DNA定序
    • 生物資訊學
    • 基因合成
  • 市場規模及預測：依組件分類
    • 寡核苷酸
    • 酵素
    • 克隆技術套件
    • 基礎生物
  • 市場規模及預測：依應用領域分類
    • 醫療應用
    • 工業應用
    • 環境應用
    • 農業應用
  • 市場規模及預測：依最終用戶分類
    • 生技公司
    • 製藥公司
    • 學術研究機構
  • 市場規模及預測：依製程分類
    • 路線工程
    • 代謝工程
    • 無細胞系統

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Ginkgo Bioworks
  • Zymergen
  • Amyris
  • Twist Bioscience
  • Synlogic
  • Codexis
  • Intrexon
  • Genomatica
  • Arzeda
  • Modern Meadow
  • Evolva
  • Biosyntia
  • Green Biologics
  • Conagen
  • Antheia
  • Benson Hill Biosystems
  • Agilent Technologies
  • Arbor Biosciences
  • Pivot Bio
  • Checkerspot

第9章：關於我們

簡介目錄
Product Code: GIS20379

Synthetic Biology Market is anticipated to expand from $13.7 billion in 2024 to $54.8 billion by 2034, growing at a CAGR of approximately 15.4%. The Synthetic Biology Market encompasses the design and construction of new biological entities or the redesign of existing biological systems. It integrates disciplines such as biology, engineering, and computer science to develop solutions for healthcare, agriculture, and environmental sustainability. This market is driven by advancements in DNA synthesis, genome editing technologies, and bioinformatics, offering transformative opportunities in biopharmaceuticals, biofuels, and biodegradable materials. Increasing investments and regulatory support are further propelling its growth.

The Synthetic Biology Market is experiencing robust expansion, propelled by advancements in genetic engineering and bioinformatics. Within this dynamic landscape, the gene synthesis sub-segment is the top performer, driven by its pivotal role in enabling precise DNA sequence creation. Synthetic genes are increasingly utilized across pharmaceuticals, agriculture, and industrial biotechnology. The second highest performing sub-segment is genome editing, particularly CRISPR technology, which has revolutionized targeted genetic modifications. Its applications span from developing disease-resistant crops to innovative therapeutic solutions. The bioinformatics segment is gaining momentum, as it provides critical tools for analyzing complex biological data. This is essential for synthetic biology research and development. Metabolic engineering also shows promise, with its capacity to optimize microbial production processes for biofuels and specialty chemicals. The convergence of these sub-segments indicates a trend towards integrated solutions that enhance efficiency and innovation. Investment in synthetic biology is poised to accelerate, unlocking new opportunities across diverse industries.

Market Segmentation
TypeGene Circuits, Chassis Organisms, DNA Synthesis, Genome Engineering
ProductSynthetic DNA, Synthetic Genes, Synthetic Cells, Xenobiology Products, Synthetic RNA
ServicesGene Synthesis Services, Genome Editing Services, Bioinformatics Services
TechnologyCRISPR, Gene Editing, DNA Sequencing, Bioinformatics, Gene Synthesis
ComponentOligonucleotides, Enzymes, Cloning Technology Kits, Chassis Organisms
ApplicationMedical Applications, Industrial Applications, Environmental Applications, Agricultural Applications
End UserBiotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes
ProcessPathway Engineering, Metabolic Engineering, Cell-free Systems

Synthetic biology is witnessing a dynamic landscape with a diverse array of market participants. The market share is increasingly fragmented as new entrants introduce innovative products. Pricing strategies are evolving, driven by technological advancements and increased competition. The industry is marked by frequent new product launches, reflecting the rapid pace of innovation. Companies are focusing on developing cost-effective solutions to capture a larger share of this burgeoning market. The emphasis on sustainable and eco-friendly products is also shaping pricing and product development strategies. The competitive landscape in synthetic biology is intense, with key players striving for technological superiority. Benchmarking reveals that leading firms are investing heavily in research and development. This is to maintain their competitive edge. Regulatory influences are significant, with stringent policies in regions like North America and Europe. These regulations impact product development and market entry strategies. The market is poised for growth, driven by advancements in gene editing and bioinformatics. However, challenges such as regulatory compliance and ethical considerations persist. These factors are pivotal in shaping the future trajectory of the synthetic biology market.

Geographical Overview:

The synthetic biology market is experiencing notable growth across diverse regions, each showcasing unique opportunities. North America leads the charge, propelled by substantial investments in research and development, alongside a robust biotechnology sector. The region's regulatory framework supports innovation, fostering a conducive environment for market expansion. Europe follows closely, with strong governmental support and funding initiatives aimed at advancing synthetic biology research. The region's commitment to sustainability and bio-based solutions enhances its market potential. In Asia Pacific, the market is rapidly growing, driven by increasing investments in biotechnology and synthetic biology startups. Countries like China and India are emerging as key players, with significant advancements in genome editing and bioengineering. Latin America and the Middle East & Africa are nascent markets with promising potential. Brazil and South Africa are witnessing rising investments in synthetic biology, recognizing its potential to transform agriculture, healthcare, and industrial processes.

The synthetic biology market is navigating a complex landscape shaped by global tariffs, geopolitical tensions, and evolving supply chain trends. In Japan and South Korea, strategic investments in biotechnology and synthetic biology are increasing as they seek to mitigate risks from trade tensions and secure technological independence. China, under pressure from export restrictions, is accelerating its domestic capabilities in synthetic biology, focusing on innovation and self-sufficiency. Taiwan, a pivotal player in semiconductor manufacturing, is diversifying its capabilities to include synthetic biology, though geopolitical risks remain a concern. Globally, the synthetic biology market is poised for robust growth, with projections indicating significant expansion by 2035. Meanwhile, Middle East conflicts contribute to supply chain volatility and energy price fluctuations, indirectly impacting production costs and market dynamics.

Key Trends and Drivers:

The synthetic biology market is experiencing robust growth, driven by advancements in genetic engineering and increased investment in biotechnology. Key trends include the development of novel synthetic organisms and bio-based products, which are transforming industries such as pharmaceuticals, agriculture, and energy. The convergence of artificial intelligence and machine learning with synthetic biology is accelerating research and development, enabling more precise and efficient design of biological systems. Another significant trend is the rising demand for sustainable and eco-friendly solutions, which is propelling the adoption of synthetic biology in creating biodegradable materials and renewable chemicals. The market is also witnessing an increase in collaborative efforts between academic institutions, research organizations, and industry players, fostering innovation and commercialization of synthetic biology applications. Government support and favorable regulatory frameworks are further catalyzing market expansion. Moreover, the growing focus on personalized medicine and the potential of synthetic biology to revolutionize disease treatment is a major driver. Companies are investing in the development of synthetic biology-based therapeutics, which promise to offer targeted and effective treatment options. The synthetic biology market is poised for significant growth as it continues to address global challenges and unlock new opportunities across various sectors.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Gene Circuits
    • 4.1.2 Chassis Organisms
    • 4.1.3 DNA Synthesis
    • 4.1.4 Genome Engineering
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Synthetic DNA
    • 4.2.2 Synthetic Genes
    • 4.2.3 Synthetic Cells
    • 4.2.4 Xenobiology Products
    • 4.2.5 Synthetic RNA
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Gene Synthesis Services
    • 4.3.2 Genome Editing Services
    • 4.3.3 Bioinformatics Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 CRISPR
    • 4.4.2 Gene Editing
    • 4.4.3 DNA Sequencing
    • 4.4.4 Bioinformatics
    • 4.4.5 Gene Synthesis
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Oligonucleotides
    • 4.5.2 Enzymes
    • 4.5.3 Cloning Technology Kits
    • 4.5.4 Chassis Organisms
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Medical Applications
    • 4.6.2 Industrial Applications
    • 4.6.3 Environmental Applications
    • 4.6.4 Agricultural Applications
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Biotechnology Companies
    • 4.7.2 Pharmaceutical Companies
    • 4.7.3 Academic and Research Institutes
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Pathway Engineering
    • 4.8.2 Metabolic Engineering
    • 4.8.3 Cell-free Systems

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Ginkgo Bioworks
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Zymergen
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Amyris
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Twist Bioscience
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Synlogic
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Codexis
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Intrexon
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Genomatica
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Arzeda
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Modern Meadow
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Evolva
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Biosyntia
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Green Biologics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Conagen
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Antheia
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Benson Hill Biosystems
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Agilent Technologies
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Arbor Biosciences
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Pivot Bio
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Checkerspot
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us